Abstract
Deriving from the Greek word for “widening”, aneurysms have been a well known entity since antiquity. In the 2nd century AD, Antyllos, the Greek born surgeon who practiced in Rome, described a method for aneurysms’ surgical removal that remained a standard procedure till the 19th century. In 18th century John Hunter proposed a limb saving operation method for treating peripheral aneurysms paving thus the way for the modern surgery of aneurysms and Rudolph Matas, carried out the first aneurysmorrhaphy. During the 20th century two eminent surgeons laid the foundations of vascular surgery: Charles Dubost, who utilized the first homograft for aneurysm repair and Michael DeBakey, who performed the first radical treatment of a thoracic aneurysm.
Keywords: History of aneurysms, history of surgery, Dacron graft, aortic surgery.
Current Pharmaceutical Design
Title:Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Volume: 21 Issue: 28
Author(s): Marianna Karamanou, Athanase Protogerou, Gerasimos Siasos, Achilleas Chatziioannou and George Androutsos
Affiliation:
Keywords: History of aneurysms, history of surgery, Dacron graft, aortic surgery.
Abstract: Deriving from the Greek word for “widening”, aneurysms have been a well known entity since antiquity. In the 2nd century AD, Antyllos, the Greek born surgeon who practiced in Rome, described a method for aneurysms’ surgical removal that remained a standard procedure till the 19th century. In 18th century John Hunter proposed a limb saving operation method for treating peripheral aneurysms paving thus the way for the modern surgery of aneurysms and Rudolph Matas, carried out the first aneurysmorrhaphy. During the 20th century two eminent surgeons laid the foundations of vascular surgery: Charles Dubost, who utilized the first homograft for aneurysm repair and Michael DeBakey, who performed the first radical treatment of a thoracic aneurysm.
Export Options
About this article
Cite this article as:
Karamanou Marianna, Protogerou Athanase, Siasos Gerasimos, Chatziioannou Achilleas and Androutsos George, Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors, Current Pharmaceutical Design 2015; 21 (28) . https://dx.doi.org/10.2174/1381612821666150826092941
DOI https://dx.doi.org/10.2174/1381612821666150826092941 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Subject Index To Volume 3
Vascular Disease Prevention (Discontinued) Effect of Cardioembolic Etiology on Intravenous Thrombolysis Efficacy for Acute Ischemic Stroke
Current Neurovascular Research Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases
Current Gene Therapy Neurological Disorders in Pregnancy
Current Women`s Health Reviews Hypopituitarism in Neurocritical Patients: A Case Report
Endocrine, Metabolic & Immune Disorders - Drug Targets Proteomic Analysis of Liver Preservation Solutions Prior to Liver Transplantation
Current Proteomics MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
Current Genomics The Anti-Inflammatory Effects of Statins on Coronary Artery Disease: An Updated Review of the Literature
Current Cardiology Reviews Endothelins and the Role of Endothelin Antagonists in the Management of Posttraumatic Vasospasm
Current Pharmaceutical Design Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
CNS & Neurological Disorders - Drug Targets The Promise of Mesenchymal Stem Cells Therapy for Acute Respiratory Distress Syndrome Caused by COVID-19
Current Stem Cell Research & Therapy Non-coding RNAs and Hypertension–Unveiling Unexpected Mechanisms of Hypertension by the Dark Matter of the Genome
Current Hypertension Reviews Atherosclerosis as an Inflammatory Disease
Current Pharmaceutical Design Coarctation of the Aorta - An Evolution of Therapeutic Options
Current Cardiology Reviews Long-Term Extensions of Randomized Vaccination Trials of ACC-001 and QS-21 in Mild to Moderate Alzheimer’s Disease
Current Alzheimer Research The Urokinase-type Plasminogen Activator and the Generation of Inhibitors of Urokinase Activity and Signaling
Current Pharmaceutical Design Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Turning Up the Pressure on Vascular Disease
Current Neurovascular Research Different Factors Influence Recanalisation Rate After Coiling in Ruptured and Unruptured Intracranial Aneurysms
CNS & Neurological Disorders - Drug Targets